AVTX Avalo Therapeutics | $6.93 -7.0% | 10/23/2026 | | Lower Price Target | $34.00 ➝ $22.00 | Outperform | 00.00% | View details for Wedbush rating of Avalo Therapeutics (NASDAQ:AVTX) on 10/23/2026 |
RBLX Roblox | $53.00 -1.8% | 10/23/2026 | | Boost Price Target | $48.00 ➝ $55.00 | Neutral | 00.00% | View details for Wedbush rating of Roblox (NYSE:RBLX) on 10/23/2026 |
BUR Burford Capital | $3.36 -0.4% | 10/22/2026 | | Reiterated Rating | $3.65 | Neutral | 00.00% | View details for Wedbush rating of Burford Capital (NYSE:BUR) on 10/22/2026 |
FMCC Freddie Mac | $3.71 -6.1% | 10/22/2026 | | Reiterated Rating | $6.00 | Outperform | 00.00% | View details for Wedbush rating of Freddie Mac (OTCMKTS:FMCC) on 10/22/2026 |
FNMA Fannie Mae | $3.99 -5.2% | 10/22/2026 | | Reiterated Rating | $3.50 | Hold | 00.00% | View details for Wedbush rating of Fannie Mae (OTCMKTS:FNMA) on 10/22/2026 |
META Meta Platforms | $642.62 -1.0% | 10/22/2026 | | Boost Price Target | $700.00 ➝ $730.00 | Neutral | 00.00% | View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 10/22/2026 |
RITM Rithm Capital | $9.40 +8.2% | 10/22/2026 | | Reiterated Rating | $10.00 | Outperform | 00.00% | View details for Wedbush rating of Rithm Capital (NYSE:RITM) on 10/22/2026 |
RPT Rithm Property Trust | $11.15 -2.6% | 10/22/2026 | | Reiterated Rating | $13.50 | Outperform | 00.00% | View details for Wedbush rating of Rithm Property Trust (NYSE:RPT) on 10/22/2026 |
S SentinelOne | $24.05 +6.9% | 10/22/2026 | | Boost Price Target | $25.00 ➝ $27.00 | Outperform | 00.00% | View details for Wedbush rating of SentinelOne (NYSE:S) on 10/22/2026 |
ABVX Abivax | $88.01 -2.5% | 10/21/2026 | | Lower Price Target | $118.00 ➝ $96.00 | Neutral | 00.00% | View details for Wedbush rating of Abivax (NASDAQ:ABVX) on 10/21/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
RCUS Arcus Biosciences | $18.54 -4.2% | 10/21/2026 | | Boost Price Target | $43.00 ➝ $49.00 | Outperform | 00.00% | View details for Wedbush rating of Arcus Biosciences (NYSE:RCUS) on 10/21/2026 |
TLX Telix Pharmaceuticals | $9.15 -4.1% | 10/21/2026 | | Reiterated Rating | $22.00 | Outperform | 00.00% | View details for Wedbush rating of Telix Pharmaceuticals (NASDAQ:TLX) on 10/21/2026 |
XNCR Xencor | $25.18 -2.6% | 10/21/2026 | | Reiterated Rating | $30.00 | Outperform | 00.00% | View details for Wedbush rating of Xencor (NASDAQ:XNCR) on 10/21/2026 |
AMD Advanced Micro Devices | $516.79 +1.7% | 10/20/2026 | | Reiterated Rating | $600.00 | Outperform | 00.00% | View details for Wedbush rating of Advanced Micro Devices (NASDAQ:AMD) on 10/20/2026 |
IRON Disc Medicine | $74.51 -0.7% | 10/19/2026 | | Boost Price Target | $100.00 ➝ $110.00 | Outperform | 00.00% | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 10/19/2026 |
VRSN VeriSign | $300.32 -1.4% | 10/19/2026 | | Boost Price Target | $341.00 ➝ $351.00 | Outperform | 00.00% | View details for Wedbush rating of VeriSign (NASDAQ:VRSN) on 10/19/2026 |
NFLX Netflix | $65.85 -1.8% | 10/16/2026 | | Lower Price Target | $105.00 ➝ $90.00 | Outperform | 00.00% | View details for Wedbush rating of Netflix (NASDAQ:NFLX) on 10/16/2026 |
VRNS Varonis Systems | $48.88 0.0% | 10/16/2026 | | Boost Price Target | $46.00 ➝ $49.75 | Neutral | 00.00% | View details for Wedbush rating of Varonis Systems (NASDAQ:VRNS) on 10/16/2026 |
DBD Diebold Nixdorf | $69.29 +0.0% | 10/15/2026 | | Reiterated Rating | $100.00 | Outperform | 00.00% | View details for Wedbush rating of Diebold Nixdorf (NYSE:DBD) on 10/15/2026 |
GFS GlobalFoundries | $44.39 +2.4% | 10/15/2026 | | Reiterated Rating | $72.00 | Neutral | 00.00% | View details for Wedbush rating of GlobalFoundries (NASDAQ:GFS) on 10/15/2026 |
STRO Sutro Biopharma | $9.33 -9.3% | 10/15/2026 | | Reiterated Rating | $60.00 | Outperform | 00.00% | View details for Wedbush rating of Sutro Biopharma (NASDAQ:STRO) on 10/15/2026 |
APP AppLovin | $260.25 -1.5% | 10/14/2026 | | Lower Price Target | $610.00 ➝ $560.00 | Outperform | 00.00% | View details for Wedbush rating of AppLovin (NASDAQ:APP) on 10/14/2026 |
BEAM Beam Therapeutics | $24.05 -2.1% | 10/14/2026 | | Reiterated Rating | $65.00 | Outperform | 00.00% | View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 10/14/2026 |
IMAX IMAX | $53.35 +2.0% | 10/14/2026 | | Boost Price Target | $54.00 ➝ $60.00 | Outperform | 00.00% | View details for Wedbush rating of IMAX (NYSE:IMAX) on 10/14/2026 |
U Unity Software | $40.87 +1.5% | 10/14/2026 | | Boost Price Target | $50.00 ➝ $55.00 | Outperform | 00.00% | View details for Wedbush rating of Unity Software (NYSE:U) on 10/14/2026 |
CTRE CareTrust REIT | $36.61 0.0% | 10/13/2026 | | Set Price Target | $44.00 | | 00.00% | View details for Wedbush rating of CareTrust REIT (NYSE:CTRE) on 10/13/2026 |
IONQ IonQ | $31.28 +0.4% | 10/13/2026 | | Reiterated Rating | $75.00 | Outperform | 00.00% | View details for Wedbush rating of IonQ (NYSE:IONQ) on 10/13/2026 |
CTSH Cognizant Technology Solutions | $70.54 -4.3% | 10/9/2026 | | Reiterated Rating | $70.00 | Outperform | 00.00% | View details for Wedbush rating of Cognizant Technology Solutions (NASDAQ:CTSH) on 10/9/2026 |
ESTC Elastic | $102.61 +4.5% | 10/9/2026 | | Reiterated Rating | $125.00 | Outperform | 00.00% | View details for Wedbush rating of Elastic (NYSE:ESTC) on 10/9/2026 |
ARGX argenex | $873.71 -0.2% | 10/8/2026 | | Lower Price Target | $1,150.00 ➝ $1,130.00 | Outperform | 00.00% | View details for Wedbush rating of argenex (NASDAQ:ARGX) on 10/8/2026 |
FLUT Flutter Entertainment | $79.98 -2.1% | 10/8/2026 | | Lower Price Target | $126.00 ➝ $110.00 | Outperform | 00.00% | View details for Wedbush rating of Flutter Entertainment (NYSE:FLUT) on 10/8/2026 |
RCKT Rocket Pharmaceuticals | $2.29 -0.9% | 10/7/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Wedbush rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 10/7/2026 |
ZS Zscaler | $255.15 +7.3% | 10/7/2026 | | Boost Price Target | $215.00 ➝ $240.00 | Outperform | 00.00% | View details for Wedbush rating of Zscaler (NASDAQ:ZS) on 10/7/2026 |
KRSA Cyclerion Therapeutics | $31.31 -6.3% | 10/5/2026 | | Initiated Coverage | $44.00 | Outperform | 00.00% | View details for Wedbush rating of Cyclerion Therapeutics (NASDAQ:KRSA) on 10/5/2026 |
STTK Shattuck Labs | $5.49 -2.0% | 10/2/2026 | | Boost Price Target | $11.00 ➝ $14.00 | Outperform | 00.00% | View details for Wedbush rating of Shattuck Labs (NASDAQ:STTK) on 10/2/2026 |
WVE WAVE Life Sciences | $3.18 -5.1% | 10/2/2026 | | Set Price Target | $13.00 | | 00.00% | View details for Wedbush rating of WAVE Life Sciences (NASDAQ:WVE) on 10/2/2026 |
LQDA Liquidia | $42.65 +7.5% | 10/2/2026 | | Set Price Target | $58.00 | | 00.00% | View details for Wedbush rating of Liquidia (NASDAQ:LQDA) on 10/2/2026 |
FHTX Foghorn Therapeutics | $2.00 -0.5% | 10/2/2026 | | Downgrade | $10.00 ➝ $2.00 | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Foghorn Therapeutics (NASDAQ:FHTX) on 10/2/2026 |
AKTS Aktis Oncology | $15.73 -6.1% | 10/2/2026 | | Reiterated Rating | $35.00 | Outperform | 00.00% | View details for Wedbush rating of Aktis Oncology (NASDAQ:AKTS) on 10/2/2026 |
CTSH Cognizant Technology Solutions | $70.54 -4.3% | 10/2/2026 | | Reiterated Rating | $70.00 | Outperform | 00.00% | View details for Wedbush rating of Cognizant Technology Solutions (NASDAQ:CTSH) on 10/2/2026 |
A letter from Shannon Stansberry (Ad) Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief.
It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live. Watch the full story and see the verified track record for yourself |
JBIO Jade Biosciences | $14.59 -2.1% | 10/1/2026 | | Reiterated Rating | $47.00 | Outperform | 00.00% | View details for Wedbush rating of Jade Biosciences (NASDAQ:JBIO) on 10/1/2026 |
RCUS Arcus Biosciences | $18.54 -4.2% | 9/30/2026 | | Reiterated Rating | $43.00 | Outperform | 00.00% | View details for Wedbush rating of Arcus Biosciences (NYSE:RCUS) on 9/30/2026 |
ZBIO Zenas BioPharma | $26.87 -4.8% | 9/30/2026 | | Reiterated Rating | $45.00 | Outperform | 00.00% | View details for Wedbush rating of Zenas BioPharma (NASDAQ:ZBIO) on 9/30/2026 |
DMRA Damora Therapeutics, Inc. Common Stock | $21.09 -2.9% | 9/29/2026 | | Reiterated Rating | $40.00 | Outperform | 00.00% | View details for Wedbush rating of Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) on 9/29/2026 |
ACET Adicet Bio | $3.99 -6.8% | 9/28/2026 | | Reiterated Rating | $25.00 ➝ $28.00 | Outperform | 00.00% | View details for Wedbush rating of Adicet Bio (NASDAQ:ACET) on 9/28/2026 |
MU Micron Technology | $877.55 +2.5% | 9/28/2026 | | Reiterated Rating | $1,400.00 | Outperform | 00.00% | View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 9/28/2026 |
ZS Zscaler | $255.15 +7.3% | 9/28/2026 | | Reiterated Rating | $215.00 | Outperform | 00.00% | View details for Wedbush rating of Zscaler (NASDAQ:ZS) on 9/28/2026 |
ORKA Oruka Therapeutics | $80.15 -1.2% | 9/24/2026 | | Set Price Target | $120.00 | | 00.00% | View details for Wedbush rating of Oruka Therapeutics (NASDAQ:ORKA) on 9/24/2026 |
EPRX Eupraxia Pharmaceuticals | $6.87 -9.5% | 9/24/2026 | | Initiated Coverage | $17.00 | Outperform | 00.00% | View details for Wedbush rating of Eupraxia Pharmaceuticals (NASDAQ:EPRX) on 9/24/2026 |
ORKA Oruka Therapeutics | $80.15 -1.2% | 9/24/2026 | | Reiterated Rating | $165.00 | Outperform | 00.00% | View details for Wedbush rating of Oruka Therapeutics (NASDAQ:ORKA) on 9/24/2026 |
P Everpure | $123.33 +1.8% | 9/24/2026 | | Reiterated Rating | $130.00 | Outperform | 00.00% | View details for Wedbush rating of Everpure (NYSE:P) on 9/24/2026 |
ROKU Roku | $158.58 -0.9% | 9/24/2026 | | Reiterated Rating | $155.00 | Neutral | 00.00% | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 9/24/2026 |
CMPX Compass Therapeutics | $0.76 -5.1% | 9/23/2026 | | Set Price Target | $4.00 | | 00.00% | View details for Wedbush rating of Compass Therapeutics (NASDAQ:CMPX) on 9/23/2026 |
MAZE Maze Therapeutics | $31.01 -2.9% | 9/23/2026 | | Reiterated Rating | $48.00 | Outperform | 00.00% | View details for Wedbush rating of Maze Therapeutics (NASDAQ:MAZE) on 9/23/2026 |
NKTR Nektar Therapeutics | $37.22 -3.7% | 9/23/2026 | | Lower Price Target | $80.00 ➝ $50.00 | Neutral | 00.00% | View details for Wedbush rating of Nektar Therapeutics (NASDAQ:NKTR) on 9/23/2026 |
SHOP Shopify | $168.68 -0.1% | 9/23/2026 | | Reiterated Rating | $176.00 | Outperform | 00.00% | View details for Wedbush rating of Shopify (NASDAQ:SHOP) on 9/23/2026 |
TLX Telix Pharmaceuticals | $9.15 -4.1% | 9/23/2026 | | Reiterated Rating | $22.00 | Outperform | 00.00% | View details for Wedbush rating of Telix Pharmaceuticals (NASDAQ:TLX) on 9/23/2026 |
WLDN Willdan Group | $72.48 +0.6% | 9/23/2026 | | Reiterated Rating | $130.00 | Outperform | 00.00% | View details for Wedbush rating of Willdan Group (NASDAQ:WLDN) on 9/23/2026 |
CMPX Compass Therapeutics | $0.76 -5.1% | 9/22/2026 | | Downgrade | $5.00 ➝ $1.00 | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Compass Therapeutics (NASDAQ:CMPX) on 9/22/2026 |
ABVX Abivax | $88.01 -2.5% | 9/22/2026 | | Lower Price Target | $140.00 ➝ $118.00 | Neutral | 00.00% | View details for Wedbush rating of Abivax (NASDAQ:ABVX) on 9/22/2026 |
IONQ IonQ | $31.28 +0.4% | 9/22/2026 | | Reiterated Rating | $75.00 | Outperform | 00.00% | View details for Wedbush rating of IonQ (NYSE:IONQ) on 9/22/2026 |
TVTX Travere Therapeutics | $50.08 -4.5% | 9/22/2026 | | Reiterated Rating | $76.00 | Outperform | 00.00% | View details for Wedbush rating of Travere Therapeutics (NASDAQ:TVTX) on 9/22/2026 |
FUBO fuboTV | $7.93 -2.8% | 9/18/2026 | | Reiterated Rating | $19.00 | Outperform | 00.00% | View details for Wedbush rating of fuboTV (NYSE:FUBO) on 9/18/2026 |
XENE Xenon Pharmaceuticals | $35.34 -3.2% | 9/18/2026 | | Lower Price Target | $71.00 ➝ $55.00 | Outperform | 00.00% | View details for Wedbush rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 9/18/2026 |
COGT Cogent Biosciences | $31.21 -0.3% | 9/16/2026 | | Reiterated Rating | $55.00 | Outperform | 00.00% | View details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 9/16/2026 |
NUVB Nuvation Bio | $4.57 -2.9% | 9/16/2026 | | Reiterated Rating | $11.00 | Outperform | 00.00% | View details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 9/16/2026 |
RCKT Rocket Pharmaceuticals | $2.29 -0.9% | 9/16/2026 | | Reiterated Rating | $15.00 | Outperform | 00.00% | View details for Wedbush rating of Rocket Pharmaceuticals (NASDAQ:RCKT) on 9/16/2026 |
SRRK Scholar Rock | $41.49 -1.1% | 9/15/2026 | | Reiterated Rating | $64.00 | Outperform | 00.00% | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 9/15/2026 |
BNTC Benitec Biopharma | $8.65 -1.9% | 9/15/2026 | | Boost Price Target | $16.00 ➝ $17.00 | Outperform | 00.00% | View details for Wedbush rating of Benitec Biopharma (NASDAQ:BNTC) on 9/15/2026 |
CATX Perspective Therapeutics | $1.61 -28.8% | 9/15/2026 | | Reiterated Rating | $11.00 | Outperform | 00.00% | View details for Wedbush rating of Perspective Therapeutics (NYSEAMERICAN:CATX) on 9/15/2026 |
SION Sionna Therapeutics | $3.60 -5.3% | 9/15/2026 | | Boost Price Target | $5.00 ➝ $6.00 | Neutral | 00.00% | View details for Wedbush rating of Sionna Therapeutics (NASDAQ:SION) on 9/15/2026 |
CBIO Crescent Biopharma | $12.82 -2.4% | 9/14/2026 | | Reiterated Rating | $27.00 | Outperform | 00.00% | View details for Wedbush rating of Crescent Biopharma (NASDAQ:CBIO) on 9/14/2026 |
RBLX Roblox | $53.00 -1.8% | 9/14/2026 | | Boost Price Target | $40.00 ➝ $48.00 | Neutral | 00.00% | View details for Wedbush rating of Roblox (NYSE:RBLX) on 9/14/2026 |
SRRK Scholar Rock | $41.49 -1.1% | 9/14/2026 | | Reiterated Rating | $64.00 | Outperform | 00.00% | View details for Wedbush rating of Scholar Rock (NASDAQ:SRRK) on 9/14/2026 |
TLX Telix Pharmaceuticals | $9.15 -4.1% | 9/14/2026 | | Reiterated Rating | $22.00 | Outperform | 00.00% | View details for Wedbush rating of Telix Pharmaceuticals (NASDAQ:TLX) on 9/14/2026 |
META Meta Platforms | $642.62 -1.0% | 9/11/2026 | | Boost Price Target | $595.00 ➝ $650.00 | Neutral | 00.00% | View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 9/11/2026 |
CRWD CrowdStrike | $257.57 +8.2% | 9/11/2026 | | Reiterated Rating | $250.00 | Outperform | 00.00% | View details for Wedbush rating of CrowdStrike (NASDAQ:CRWD) on 9/11/2026 |
DDOG Datadog | $269.65 +4.6% | 9/11/2026 | | Initiated Coverage | $260.00 ➝ $275.00 | Outperform | 00.00% | View details for Wedbush rating of Datadog (NASDAQ:DDOG) on 9/11/2026 |
ESTC Elastic | $102.61 +4.5% | 9/11/2026 | | Initiated Coverage | $125.00 | Outperform | 00.00% | View details for Wedbush rating of Elastic (NYSE:ESTC) on 9/11/2026 |
PANW Palo Alto Networks | $380.55 +7.2% | 9/11/2026 | | Initiated Coverage | $400.00 | Outperform | 00.00% | View details for Wedbush rating of Palo Alto Networks (NASDAQ:PANW) on 9/11/2026 |
RBRK Rubrik | $129.18 +7.0% | 9/11/2026 | | Initiated Coverage | $90.00 ➝ $120.00 | Outperform | 00.00% | View details for Wedbush rating of Rubrik (NYSE:RBRK) on 9/11/2026 |
S SentinelOne | $24.05 +6.9% | 9/11/2026 | | Initiated Coverage | $25.00 | Outperform | 00.00% | View details for Wedbush rating of SentinelOne (NYSE:S) on 9/11/2026 |
VRNS Varonis Systems | $48.88 0.0% | 9/11/2026 | | Reiterated Rating | $46.00 | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Varonis Systems (NASDAQ:VRNS) on 9/11/2026 |
ZS Zscaler | $255.15 +7.3% | 9/11/2026 | | Initiated Coverage | $215.00 | Outperform | 00.00% | View details for Wedbush rating of Zscaler (NASDAQ:ZS) on 9/11/2026 |
QLYS Qualys | $216.70 +4.1% | 9/10/2026 | | Downgrade | $175.00 | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Qualys (NASDAQ:QLYS) on 9/10/2026 |
TLS Telos | $4.87 +6.6% | 9/10/2026 | | Downgrade | $5.00 | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Telos (NASDAQ:TLS) on 9/10/2026 |
DT Dynatrace | $64.14 +1.2% | 9/10/2026 | | Downgrade | $54.00 | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Dynatrace (NYSE:DT) on 9/10/2026 |
CHKP Check Point Software Technologies | $159.03 +4.6% | 9/10/2026 | | Downgrade | $135.00 | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Check Point Software Technologies (NASDAQ:CHKP) on 9/10/2026 |
TENB Tenable | $44.59 +6.2% | 9/10/2026 | | Downgrade | $29.00 | Outperform ➝ Underperform | 00.00% | View details for Wedbush rating of Tenable (NASDAQ:TENB) on 9/10/2026 |
PYXS Pyxis Oncology | $1.68 -1.8% | 9/10/2026 | | Boost Price Target | $6.00 ➝ $8.00 | Outperform | 00.00% | View details for Wedbush rating of Pyxis Oncology (NASDAQ:PYXS) on 9/10/2026 |
Why Gerardo Del Real says wait before buying uranium stocks (Ad) Gerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he says has never existed before.
In a similar setup in the past, select investors saw $1,000 turn into over $1 million within a few years.
Del Real just released a full video breakdown of what is driving this move and how to prepare. Watch Gerardo Del Real's new uranium market breakdown now |
DDOG Datadog | $269.65 +4.6% | 9/10/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Wedbush rating of Datadog (NASDAQ:DDOG) on 9/10/2026 |
DT Dynatrace | $64.14 +1.2% | 9/10/2026 | | Upgrade | | Hold | 00.00% | View details for Wedbush rating of Dynatrace (NYSE:DT) on 9/10/2026 |
IMUX Immunic | $7.41 +2.6% | 9/10/2026 | | Reiterated Rating | $45.00 | Outperform | 00.00% | View details for Wedbush rating of Immunic (NASDAQ:IMUX) on 9/10/2026 |
IRD Opus Genetics | $3.47 -9.2% | 9/10/2026 | | Boost Price Target | $10.00 ➝ $13.00 | Outperform | 00.00% | View details for Wedbush rating of Opus Genetics (NASDAQ:IRD) on 9/10/2026 |
IRON Disc Medicine | $74.51 -0.7% | 9/10/2026 | | Reiterated Rating | $100.00 | Outperform | 00.00% | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 9/10/2026 |
QLYS Qualys | $216.70 +4.1% | 9/10/2026 | | Upgrade | | Hold | 00.00% | View details for Wedbush rating of Qualys (NASDAQ:QLYS) on 9/10/2026 |
TENB Tenable | $44.59 +6.2% | 9/10/2026 | | Upgrade | | Strong Sell | 00.00% | View details for Wedbush rating of Tenable (NASDAQ:TENB) on 9/10/2026 |
TLS Telos | $4.87 +6.6% | 9/10/2026 | | Upgrade | | Hold | 00.00% | View details for Wedbush rating of Telos (NASDAQ:TLS) on 9/10/2026 |
TYRA Tyra Biosciences | $20.45 -2.0% | 9/10/2026 | | Reiterated Rating | $53.00 | Outperform | 00.00% | View details for Wedbush rating of Tyra Biosciences (NASDAQ:TYRA) on 9/10/2026 |
VRNS Varonis Systems | $48.88 0.0% | 9/10/2026 | | Upgrade | | Hold | 00.00% | View details for Wedbush rating of Varonis Systems (NASDAQ:VRNS) on 9/10/2026 |